The ratio of C24:0/C16:0 ceramides in blood may be a valuable new biomarker of CHD risk, HF risk, and all-cause mortality in the community.
No takes yet. Share an insight, caveat, or question.
Peterson et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: